Samsung Bioepis to Launch Ophthalmology Biosimilar in U.S. in 2027
Seoul: Samsung Bioepis Co., the biosimilar drug development arm of Samsung Group, announced its plans to introduce its ophthalmology biosimilar, Opuviz, to the United States
Seoul: Samsung Bioepis Co., the biosimilar drug development arm of Samsung Group, announced its plans to introduce its ophthalmology biosimilar, Opuviz, to the United States
Cj cheiljedang corp.: CJ Cheiljedang Corp. on Thursday outlined corrective measures after South Korea’s antitrust regulator imposed a hefty fine on the company for colluding
Busan: South Korea’s Navy and Marine Corps are set to participate in the multinational Cobra Gold drills in Thailand, marking a significant effort to enhance
Sk group chairman chey tae-won:on, who heads the Korea Chamber of Commerce and Industry (KCCI), on Thursday called for all-out reform of the business lobby
Milan: Samsung Electronics Co. announced on Thursday that it has equipped the short track speed skating venue at the 2026 Milan-Cortina Winter Olympics with state-of-the-art
Seoul: South Korea’s antitrust regulator announced that it has levied a total fine of 408.3 billion won (US$283.9 million) on the nation’s three primary sugar
Seoul: A court is set to deliver its verdict Thursday in the trial of former Interior Minister Lee Sang-min, who is accused of playing a
Seoul: HD Hyundai Co. on Thursday reported its 2025 net profit of 3.67 trillion won (US$2.6 billion), marking a 90.4 percent increase from the previous
Copyright ©2026 Korea News Gazette. All Rights Reserved.